Drug class

Platinum Compounds

Platinum compounds are a class of metal-coordination antineoplastic agents—including cisplatin, carboplatin, and oxaliplatin—that function primarily by forming covalent intra- and interstrand DNA cross-links. Read more about Platinum Compounds

46 drugs in this class 28 manufacturers

Advertisement

Drugs in Platinum Compounds

Showing 37–45 of 46 drugs

CISPLATIN

PLATINUM COMPOUNDS · OVARIAN GERM CELL TUMOR CARCINOMA ·+5
FOSUN PHARMA US

OXALIPLATIN

PLATINUM COMPOUNDS · METASTATIC COLORECTAL CANCER ·+1
NEXTGEN PHARMAC

OXALIPLATIN

PLATINUM COMPOUNDS · METASTATIC COLORECTAL CANCER ·+1
APOTEX/NOVAPLUS

OXALIPLATIN

PLATINUM COMPOUNDS · METASTATIC COLORECTAL CANCER ·+1
MEITHEAL-PREMIE

CARBOPLATIN

PLATINUM COMPOUNDS · MALIGNANT NEOPLASM OF THE OVARY ·+3
Hospira

OXALIPLATIN

PLATINUM COMPOUNDS · METASTATIC COLORECTAL CANCER ·+1
FRESENIUS KABI

CARBOPLATIN

PLATINUM COMPOUNDS · MALIGNANT NEOPLASM OF THE OVARY ·+3
FRESENIUS KABI

CISPLATIN

PLATINUM COMPOUNDS · OVARIAN GERM CELL TUMOR CARCINOMA ·+5
FRESENIUS KABI
Filter & compare in the drug finder → Opens the drug finder with Platinum Compounds preselected. Add indication or manufacturer filters there.

About Platinum Compounds.

Platinum compounds are a class of metal-coordination antineoplastic agents—including cisplatin, carboplatin, and oxaliplatin—that function primarily by forming covalent intra- and interstrand DNA cross-links.

This DNA binding disrupts vital transcription and replication pathways, inducing cellular DNA damage responses and apoptotic cell death in rapidly dividing cells.

These agents serve as foundational components of combination chemotherapy regimens across a broad spectrum of malignancies, most notably testicular, ovarian, lung, bladder, and colorectal cancers.